Brazil to receive first doses of China's Sinovac COVID-19 vaccine this week
Published
The temporary halt had no affect on the clinical trials, says Butantan Institute chief
Full ArticlePublished
The temporary halt had no affect on the clinical trials, says Butantan Institute chief
Full ArticleWashington Post columnist Megan McArdle was anxious to tell readers that drug development in the pandemic has been a great..
The announcement by pharmaceutical company Pfizer that trials of its coronavirus (COVID-19) vaccine could be more than 90 percent..